Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 3, 2012
Issued Date -
N/A
app pub date -
May 14, 2009
filing date -
May 14, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The application provides methods of prognosing and classifying lung cancer patients into poor survival groups or good survival groups and for determining the benefit of adjuvant chemotherapy by way of a multigene signature. The application also includes kits and computer products for use in the methods of the application.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully